NVNO Stock Summary and Trading Ideas (Envveno Medical | NASDAQ:NVNO)

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Envveno Medical trades on the NASDAQ stock market under the symbol NVNO.

As of February 2, 2026, NVNO stock price declined to $11.11 with 21,759 million shares trading.

NVNO has a beta of 2.12, meaning it tends to be more sensitive to market movements. NVNO has a correlation of 0.04 to the broad based SPY ETF.

NVNO has a market cap of $7.28 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, NVNO traded as high as $243.95 and as low as $9.42.

The top ETF exchange traded funds that NVNO belongs to (by Net Assets): VXF, IWC.

NVNO has underperformed the market in the last year with a price return of -90.3% while the SPY ETF gained +16.1%. NVNO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -54.5% and -7.2%, respectively, while the SPY returned +2.6% and +0.5%, respectively.

NVNO support price is $10.86 and resistance is $13.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NVNO shares will trade within this expected range on the day.